Use of Neem oil and for treatment of calcinosis-related skin ulcers in systemic sclerosis.

OBJECTIVE

This study evaluated Neem oil and (Holoil®) for treatment of scleroderma skin ulcers related to calcinosis (SU-calc). We retrospectively analyzed 21 consecutive systemic sclerosis (SSc) patients with a total of 33 SU-calcs treated daily with Holoil® cream compared with a control group of 20 patients with 26 SU-calcs. Holoil® was directly applied to skin lesions, while the control group received only standard medication.

RESULTS

Application of Holoil® either resulted in crushing and complete resolution of calcium deposits or facilitated sharp excision of calcinosis during wound care sessions in 27/33 cases (81.8%). Complete healing of SU-calc occurred in 15/33 (45%) of cases within a time period of 40.1 ± 16.3 (mean ± SD) days, while 18/33 (55%) of lesions improved in terms of size, erythema, fibrin and calcium deposits. Patients reported a reduction of pain (mean numeric rating scale 7.3 ± 1.9 at baseline versus 2.9 ± 1.4 at follow-up) The control group had longer healing times and a higher percentage of infections.

CONCLUSIONS

The efficacy of local treatment with neem oil and suggest that Holoil® could be a promising tool in the management of SSc SU-calc.